BioCryst Pharmaceuticals (BCRX)
(Delayed Data from NSDQ)
$4.16 USD
0.00 (0.00%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.15 -0.01 (-0.24%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/06/2024
Time: BMO |
3/2024 | $-0.23 | 11.11% |
Earnings Summary
For their last quarter, BioCryst Pharmaceuticals (BCRX) reported earnings of -$0.28 per share, missing the Zacks Consensus Estimate of -$0.24 per share. This reflects a negative earnings surprise of 16.67%. Look out for BCRX's next earnings release on May 06, 2024. For the next earning release, we expect the company to report earnings of -$0.23 per share, reflecting a year-over-year increase of 17.86%.
Earnings History
Price & Consensus
Zacks News for BCRX
Ionis' (IONS) Donidalorsen Meets Late-Stage HAE Study Goal
BCRX: What are Zacks experts saying now?
Zacks Private Portfolio Services